APA (7th ed.) Citation

AR, S. N. A., Mohd Khialdin, S., Mustapha, M., MS, M. S., & MZ, A. (2022). Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block. Universiti Kebangsaan Malaysia. Faculty of Medicine.

Chicago Style (17th ed.) Citation

AR, Siti Noor Atikah, Safinaz Mohd Khialdin, Mushawiahti Mustapha, Muhammad Syamil MS, and Ayesha MZ. Intracameral Recombinant Tissue Plasminogen Activator (rtPA) as the Primary Treatment for Secondary Pupillary Block. Universiti Kebangsaan Malaysia. Faculty of Medicine, 2022.

MLA (9th ed.) Citation

AR, Siti Noor Atikah, et al. Intracameral Recombinant Tissue Plasminogen Activator (rtPA) as the Primary Treatment for Secondary Pupillary Block. Universiti Kebangsaan Malaysia. Faculty of Medicine, 2022.